Sponsor Pipeline

AllRock Bio, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-11 NCT07175038
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary…		 Trial sites expanded: 19 -> 23 locations
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07175038 A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary… Pulmonary Arterial Hypertension (PAH) Recruiting
Disease Areas
Hypertension (1)
Get alerts when AllRock Bio, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free